Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · IEX Real-Time Price · USD
0.760
+0.013 (1.75%)
Apr 23, 2024, 3:12 PM EDT - Market open
Psyence Biomedical Statistics
Total Valuation
PBM has a market cap or net worth of $10.18 million. The enterprise value is $10.22 million.
Market Cap | 10.18M |
Enterprise Value | 10.22M |
Important Dates
The next estimated earnings date is Thursday, May 2, 2024, before market open.
Earnings Date | May 2, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
PBM has 13.39 million shares outstanding. The number of shares has decreased by -73.03% in one year.
Shares Outstanding | 13.39M |
Shares Change (YoY) | -73.03% |
Shares Change (QoQ) | -4.27% |
Owned by Insiders (%) | 94.87% |
Owned by Institutions (%) | 15.82% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 6.75 |
EV / Sales | n/a |
EV / EBITDA | 6.75 |
EV / EBIT | 6.75 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
Current Ratio | 0.01 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -10.10% and return on invested capital (ROIC) is 14.63%.
Return on Equity (ROE) | -10.10% |
Return on Assets (ROA) | 2.00% |
Return on Capital (ROIC) | 14.63% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | -0.06 |
52-Week Price Change | n/a |
50-Day Moving Average | 0.94 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 39.81 |
Average Volume (30 Days) | 3,610,358 |
Short Selling Information
The latest short interest is 7,777, so 0.06% of the outstanding shares have been sold short.
Short Interest | 7,777 |
Short Previous Month | 5,226 |
Short % of Shares Out | 0.06% |
Short % of Float | n/a |
Short Ratio (days to cover) | 9.75 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -2.35M |
Pretax Income | 1.52M |
Net Income | 1.52M |
EBITDA | 1.52M |
EBIT | 1.52M |
Earnings Per Share (EPS) | -$0.01 |
Balance Sheet
The company has $88,174 in cash and no debt, giving a net cash position of $88,174 or $0.01 per share.
Cash & Cash Equivalents | 88,174 |
Total Debt | n/a |
Net Cash | 88,174 |
Net Cash Per Share | $0.01 |
Equity / Book Value | -16.07M |
Book Value Per Share | -1.20 |
Working Capital | -16.02M |
Cash Flow
Operating Cash Flow | -1.14M |
Capital Expenditures | n/a |
Free Cash Flow | -1.14M |
FCF Per Share | -$0.15 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PBM does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 73.03% |
Shareholder Yield | 73.03% |
Earnings Yield | 14.70% |
FCF Yield | -11.05% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 3 |